Catalyst Wire Dossier Catalyst Wire Dossier

PF-00610355

· Pfizer
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for PF-00610355, covering 2010-04-27 to 2019-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients. [Phase 2]

See pricing